
The new site will expand research capabilities across immunology, neuroscience and oncology

The use of Rinvoq in non-segmental vitiligo is under regulatory review by the US FDA

Rinvoq is the first and only systemic medication approved in the EU for NSV

The acquisition includes clinical-stage candidates for atopic dermatitis and asthma

ALS is a progressive neurodegenerative disease that affects the motor neurons of the brain and spinal cord

The company has been given manufacturing and marketing authorisation for the therapy

Spanning four dimensions of skin health, the framework introduces 15 terms and definitions

The platform will passively collect data to understand treatment responses in everyday life

The pharma company has also pledged a $100bn investment in US infrastructure over the next decade

The company also received a grant from the Michael J. Fox Foundation and Parkinson’s UK

The US-based company develops light-based therapies for neurodegenerative conditions

Alessio Ciulli has been appointed as Chair of the board